RENAGEL
RENAGEL
Discontinued
DIN Number
02241701
Drug Class
Human
Market Date
Aug 14, 2000
Company
HC
sanofi genzyme, a division of sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02241701
AIG Number0139865001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AE02 SEVELAMER
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification40:18.19
Health Canada Classification
ACTIVE INGREDIENTS (1)
SEVELAMER HYDROCHLORIDEActive
Strength: 403 MG
Monograph: SEVELAMER HYDROCHLORIDE